TrimRx's Blog

Intermittent fasting was the dominant weight loss conversation from about 2016 to 2022.

“Ozempic face” is the gaunt, hollowed look that shows up in some patients after rapid GLP-1 weight loss.

Contrave came to market in 2014 as the first oral combination weight loss drug approved by the FDA in nearly a decade.

For the last 30 years, bariatric surgery was the only reliable way to lose 25% or more of body weight and keep it off for years.

Plant-based eaters using GLP-1 medications face a specific challenge: meeting protein needs during caloric restriction with reduced appetite.

Introduction By early 2023 it was an open secret in Los Angeles that producers, actors, and wedding-bound brides were getting Ozempic® and Mounjaro® for…

Vacations are designed to break routine.

Adding a GLP-1 to insulin is one of the most evidence-supported combinations in type 2 diabetes care.

Long-haul truck drivers have one of the highest obesity rates of any US occupation.